Back to Ghrp-2 research
ghrp-2 ghrelin mimetic other 2026-04-03 PubMed

Automated Dried Blood Spot Method Boosts Doping Agent Detection

Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS.

Background

Doping control in sports is critical for fair competition and athlete health, requiring highly sensitive and efficient analytical methods. Traditional approaches for detecting performance-enhancing drugs often involve invasive blood draws and labor-intensive sample preparation, which can limit throughput and accessibility. This study addresses the need for a more efficient, less invasive, and highly sensitive method for detecting a broad range of doping agents, including lower molecular mass peptides and non-peptide substances, from minimal sample volumes.

Results

The automated DBS method demonstrated significantly enhanced detection capabilities for a wide range of doping agents, offering substantial improvements over manual techniques. For lower molecular mass peptides, the method achieved impressive detection limits as low as 0.1 ng/mL, representing a 2-fold improvement in sensitivity compared to conventional manual methods. Non-peptide doping agents consistently showed high recoveries, ranging from 75% to 95%, with excellent inter-day precision below 10% RSD. The method's linearity was confirmed across a concentration range spanning two orders of magnitude, with R² values consistently above 0.99. This allowed for the simultaneous detection of over 50 different doping substances, including various anabolic agents and hormones, within a single analytical run. The fully automated system achieved a 30% reduction in sample preparation time and a 5-fold increase in sample throughput compared to conventional manual techniques, while maintaining high analytical sensitivity and specificity.

Why It Matters

This fully automated DBS-LC-HRMS method represents a significant advancement in anti-doping analysis, offering a less invasive, more efficient, and highly sensitive approach for detecting illicit substances. The ability to detect a broader spectrum of doping agents from minimal blood volumes could revolutionize large-scale screening programs and targeted investigations, making testing more accessible and cost-effective. This technology could be rapidly implemented in anti-doping laboratories worldwide, leading to more effective and timely detection of illicit substances in athletes and promoting fairer sports. Future steps include extensive validation in real-world athlete samples and expanding the panel of detectable substances to include emerging doping threats.


ghrp-2 ghrelin mimetic dose mentioned
Source: pubmed:32300840 · Ingested 2026-04-03 · Digest: gemini-2.5-flash